MS
Insider
Matthew Shields
EVP, Global OperationsMatthew Shields (EVP, Global Operations) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $548K of TEVA (17,295 sh × $31.67, as filed), executed Mar 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Jun 18
Filed Jun 22
Median ADV $196.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TEVARecent filings
TEVASALE
Teva Pharmaceutical Industries Limited
View filing →
$322K9,989 sh × $32.19
Exec Jun 18
Filed Jun 22 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $532K
16,195 sh × $32.87
Exec Jun 3
Filed Jun 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $548K
17,295 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $106K
6,206 sh × $17.02
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET